IFNG and glioblastoma: We confirmed this finding by IHC of archived FFPE tumor sections from both newly diagnosed and matched recurrent GBM patients, where the majority of samples (80%) showed PDL1 staining, some with focal staining consistent with site-specific upregulation in response to IFNγ produced by infiltrating immune cells.